Morning Market Movers
December 24, 2014 at 09:42 AM EST
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) rose 27.64% to $18.70 after the FDA approved a New Drug Application for Adamas ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.